Prescription Diversion Summit

In order to view the Prescription Diversion Summit lectures you must be registered with our office. If you would like to view any of the sessions listed below, please log in to with your username and password. If you have not received a secure login and password, please request one. You will receive an email once it has been created.

Prescription Diversion Summit was offered June 7, 2014 and jointly provided by the Warren Alpert Medical School of Brown University and the Rhode Island Department of Health in partnership with the University of Rhode Island College of Pharmacy, US Department of Justice, the US Department of Justice Drug Enforcement Administration, and the Rhode Island Medical Society.

Program Description

This multidisciplinary program presented by local experts, will provide practitioners with critical insights into the scope of the problem of prescription drug diversion and abuse in Rhode Island. Critical tools and strategies available to address abuse from the exam room to the emergency room to the counter of the neighborhood pharmacy will be presented.

Target Audience

Physicians, Pharmacists, Physician Assistants, Advanced Practice Nurse Practitioners, and Other Healthcare Providers

Learning Objectives

At the conclusion of this activity, participants should be able to:

  1. Describe the scope of the prescription drug abuse and diversion problem in Rhode Island
  2. Explain Rhode Island’s Prescription Monitoring Program (PMP) use to date and barriers to adoption
  3. Discuss how the PMP can be used to assess treatment, coordinate care and detect a problem
  4. Evaluate patient risks and apply strategies to prevent prescription drug abuse and diversion

Please note these sessions are not approved for AMA PRA Category 1 Credit™.

Opening Remarks and Diversion: The Scope and Mechanics of
the Problem
Moderator: Traci C. Green, MSc, PhD

Discussion of Epidemiology
Traci C. Green, MSc, PhD

How Diversion Happens: MD Perspective
John P. Femino, MD, FASAM

How Diversion Happens: DEA Perspective
Todd F. Prough

Drug Seeking, Addict, and Pharmacy Perspective
Jake Nichols, PharmD
Practitioner’s Toolbox, Part I: Focus on the RI PMP

The RI Prescription Monitoring Program (PMP)
James V. McDonald, MD, MPH and Gary Bubly, MD, FACEP
Practitioners Toolbox, Part II: Best Practices to Prevent Abuse & Diversion
Moderator: Peter D. Friedmann, MD, MPH

Evaluating Addiction and Misuse Risk
John P. Femino, MD, FASAM

Alternatives to Opioids
Matthew J. Smith, MD, FAAPM&R

Controlled Prescribing: Pain Contracts, Pill Quantities, Federal State Board Regulations, etc.
Peter D. Friedmann, MD, MPH

Corresponding Responsibility and Use of PMP in the Pharmacy
Leo J. Lariviere, BS
Practitioner's Toolbos, Part III: Best Practices to Address Prescription Drug Abuse
Moderator: Peter D. Friedmann, MD, MPH

Addressing Aberrant Opioid Use Behavior
Peter D. Friedmann, MD, MPH

Addiction Treatment Resources
Josiah D. Rich, MD, MPH

Controlled Substance Disposal: Take Back Programs
Jayne Pawasauskas, PharmD, BCPS

Please note these sessions are not approved for AMA PRA Category 1 Credit™.